A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type...
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2013
|
_version_ | 1826274547293224960 |
---|---|
author | Mangravite, L Engelhardt, B Medina, M Smith, J Brown, C Chasman, D Mecham, B Howie, B Shim, H Naidoo, D Feng, Q Rieder, M Chen, Y Rotter, J Ridker, P Hopewell, J Parish, S Armitage, J Collins, R Wilke, R Nickerson, D Stephens, M Krauss, R |
author_facet | Mangravite, L Engelhardt, B Medina, M Smith, J Brown, C Chasman, D Mecham, B Howie, B Shim, H Naidoo, D Feng, Q Rieder, M Chen, Y Rotter, J Ridker, P Hopewell, J Parish, S Armitage, J Collins, R Wilke, R Nickerson, D Stephens, M Krauss, R |
author_sort | Mangravite, L |
collection | OXFORD |
description | Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type 2 diabetes. Despite evidence for substantial genetic influence on LDL concentrations, pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy or toxicity, and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment. This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy. |
first_indexed | 2024-03-06T22:45:05Z |
format | Journal article |
id | oxford-uuid:5ce3fa11-eadf-48ae-84d1-97f65f4d314a |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T22:45:05Z |
publishDate | 2013 |
record_format | dspace |
spelling | oxford-uuid:5ce3fa11-eadf-48ae-84d1-97f65f4d314a2022-03-26T17:31:08ZA statin-dependent QTL for GATM expression is associated with statin-induced myopathy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5ce3fa11-eadf-48ae-84d1-97f65f4d314aEnglishSymplectic Elements at Oxford2013Mangravite, LEngelhardt, BMedina, MSmith, JBrown, CChasman, DMecham, BHowie, BShim, HNaidoo, DFeng, QRieder, MChen, YRotter, JRidker, PHopewell, JParish, SArmitage, JCollins, RWilke, RNickerson, DStephens, MKrauss, RStatins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type 2 diabetes. Despite evidence for substantial genetic influence on LDL concentrations, pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy or toxicity, and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment. This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy. |
spellingShingle | Mangravite, L Engelhardt, B Medina, M Smith, J Brown, C Chasman, D Mecham, B Howie, B Shim, H Naidoo, D Feng, Q Rieder, M Chen, Y Rotter, J Ridker, P Hopewell, J Parish, S Armitage, J Collins, R Wilke, R Nickerson, D Stephens, M Krauss, R A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title_full | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title_fullStr | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title_full_unstemmed | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title_short | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. |
title_sort | statin dependent qtl for gatm expression is associated with statin induced myopathy |
work_keys_str_mv | AT mangravitel astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT engelhardtb astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT medinam astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT smithj astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT brownc astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT chasmand astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT mechamb astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT howieb astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT shimh astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT naidood astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT fengq astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT riederm astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT cheny astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT rotterj astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT ridkerp astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT hopewellj astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT parishs astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT armitagej astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT collinsr astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT wilker astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT nickersond astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT stephensm astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT kraussr astatindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT mangravitel statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT engelhardtb statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT medinam statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT smithj statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT brownc statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT chasmand statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT mechamb statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT howieb statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT shimh statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT naidood statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT fengq statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT riederm statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT cheny statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT rotterj statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT ridkerp statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT hopewellj statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT parishs statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT armitagej statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT collinsr statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT wilker statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT nickersond statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT stephensm statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy AT kraussr statindependentqtlforgatmexpressionisassociatedwithstatininducedmyopathy |